WILLIAM LYMAN: Open Payments
NPI 1760003321 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 69 payments from 19 companies in 2025. Trend: 2023 $1,122 · 2024 $2,084 · 2025 $1,728
Food & beverage: $1,728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $290 |
| Vanda Pharmaceuticals Inc. | 8 | $284 |
| Axsome Therapeutics, Inc. | 6 | $153 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Almatica Pharma LLC | 4 | $106 |
| Janssen Pharmaceuticals, Inc | 4 | $103 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Biogen, Inc. | 3 | $74 |
| Alkermes, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
Products named: VRAYLAR, FANAPT, Auvelity, COBENFY, LOREEV XR, REXULTI, INVEGA SUSTENNA, ARISTADA.
Industry payments across IL — which companies pay providers there.
